Page last updated: 2024-11-06

phentolamine and Centriacinar Emphysema

phentolamine has been researched along with Centriacinar Emphysema in 3 studies

Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gould, L3
DeMartino, A2
Gomprecht, RF2
Umali, F1
Michael, A1
Dilieto, M1
Zahir, M1

Other Studies

3 other studies available for phentolamine and Centriacinar Emphysema

ArticleYear
Hemodynamic effects of phentolamine in cor pulmonale.
    The Journal of clinical pharmacology and new drugs, 1972, Volume: 12, Issue:4

    Topics: Blood Pressure; Carbon Dioxide; Cardiac Catheterization; Cardiac Output; Chronic Disease; Heart Rate

1972
Phentolamine, new bronchodilator.
    New York state journal of medicine, 1970, Sep-15, Volume: 70, Issue:18

    Topics: Adult; Bronchodilator Agents; Humans; Isoproterenol; Male; Phentolamine; Pulmonary Emphysema

1970
Haemodynamic effects of phentolamine in chronic obstructive pulmonary disease.
    British heart journal, 1971, Volume: 33, Issue:4

    Topics: Adult; Aged; Blood Pressure; Brachial Artery; Bronchitis; Carbon Dioxide; Cardiac Catheterization; C

1971